MarketPeel
Insider Trading Intelligence
DB

Dror Bashan

PLX
PRESIDENT AND CEO · PROTALIX BIOTHERAPEUTICS, INC. · CIK 0001781450
FILING MIX · LIFETIME100%/0%
BUYS
12
SELLS
0
TOTAL VALUE
$293.8K
COMPANIES
1
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
188,516
AVG SELL PX
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dror Bashan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%+0.06%-1.38%+1.44%+4.25%
14d4+75.00%+3.59%-0.05%+3.63%+7.47%
30d4+25.00%-4.13%+0.58%-4.72%-9.82%
60d4+75.00%+23.54%+2.80%+20.74%+10.11%
90d4+75.00%+4.56%+1.77%+2.79%-5.72%
180d4+25.00%-12.75%+7.82%-20.57%-25.13%
1y4(1 pending)+33.33%+5.33%+24.20%-18.87%-64.28%
2y4(1 pending)+66.67%+14.72%+46.13%-31.42%-31.52%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLX · 188,516 shares · as of Dec 19, 2025
0586,1051,172,2091,758,3142,344,41820212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 12 buys / 0 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
PRESIDENT AND CEO
56,000$1.81$101.4K188,516Dec 19, 2025Dec 23, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
195,0002,344,418Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
340,000340,000Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
263,9602,149,418Apr 1, 2024Apr 3, 2024View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
PRESIDENT AND CEO
48,387$1.40$67.7K116,387Oct 19, 2023Oct 20, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
PRESIDENT AND CEO
16,129$1.41$22.7K132,516Oct 19, 2023Oct 20, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
800,0001,885,458Aug 15, 2023Aug 17, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
750,000750,000Sep 7, 2022Sep 9, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
President and CEO
68,000$1.50$102.0K68,000Apr 11, 2022Apr 13, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
637,5311,085,458Feb 25, 2022Feb 28, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
447,927447,927Aug 11, 2020Aug 14, 2020View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
447,927447,927Aug 11, 2020Aug 13, 2020View →
Other insiders · PLX
Loading peer insiders…
About this filer
CIK 0001781450
ROLE
President and CEO
PRIMARY
PLX
COMPANIES
1
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001781450DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback